Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹13 Cr
Revenue (TTM)
₹1 Cr
Net Profit (TTM)
₹-12 Cr
ROE
2.6 %
ROCE
3.8 %
P/E Ratio
--
P/B Ratio
9.6
Industry P/E
10.59
EV/EBITDA
-1.1
Div. Yield
0 %
Debt to Equity
0
Book Value
₹9
EPS
₹-80.9
Face value
10
Shares outstanding
1,500,000
CFO
₹1.03 Cr
EBITDA
₹-5.41 Cr
Net Profit
₹6.36 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Star Source Multi Trade
| -24.3 | -17.8 | -25.7 | -17.2 | 31.7 | 35.9 | 15.5 |
|
BSE 500
| -7.6 | -7.0 | -6.9 | 7.4 | 14.4 | 11.8 | 13.3 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Star Source Multi Trade
| 8.2 | 63.2 | 59.0 | 25.0 | 17.9 | 279.5 | -74.9 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE 500
| 6.4 | 14.4 | 24.8 | 3.3 | 30.1 | 16.8 | 7.8 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Star Source Multi Trade
|
86.8 | 13.0 | 0.5 | -12.1 | -2,249.6 | -166.4 | -- | 9.6 |
| 164.6 | 2,811.3 | 2,581.3 | 196.0 | 10.4 | 13.7 | 10.5 | 1.4 | |
| 24.0 | 94.5 | 278.7 | 8.9 | 5.4 | 10.7 | 10.6 | 1.3 | |
| 41.3 | 50.9 | 101.3 | 4.5 | -- | 26.4 | 11.3 | 2.7 | |
| 175.9 | 1,899.6 | 165.7 | -17.0 | -10.8 | -7.5 | -- | 6.8 | |
| 565.5 | 16,003.7 | 4,166.3 | 1,205.1 | 32.1 | 11.4 | 17.9 | 1.9 | |
| 338.6 | 367.7 | 101.0 | 15.9 | -- | 16.7 | 23.1 | 3.5 | |
| 22.8 | 9.0 | 0.0 | -0.5 | -- | -14.2 | -- | 2.6 | |
| 551.5 | 140.6 | 97.8 | 23.0 | 5.4 | 6.2 | 8.2 | 1.6 |
No Review & Analysis are available.
Chemo Pharma Laboratories Limited does not have significant operations. Previously, it was engaged in the finance and investment activities. The company was founded in 1942 and is based in Mumbai, India.
Incorporated
1942
Chairman
--
Managing Director
Ruchit Mehta
Headquarters
Thane, Maharashtra
Website
Looking for more details about Star Source Multi Trade Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View Announcements
The share price of Star Source Multi Trade Ltd is ₹86.81 (BSE) as of 18-Mar-2026 IST. Star Source Multi Trade Ltd has given a return of 31.7% in the last 3 years.
Since, TTM earnings of Star Source Multi Trade Ltd is negative, P/E ratio is not available.
The P/B ratio of Star Source Multi Trade Ltd is 9.64 times as on 18-Mar-2026, a 506 premium to its peers’ median range of 1.59 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
54.62
|
1.42
|
|
2024
|
8.12
|
0.76
|
|
2023
|
126.52
|
0.52
|
|
2022
|
11.06
|
0.54
|
|
2021
|
10.71
|
0.24
|
The 52-week high and low of Star Source Multi Trade Ltd are Rs 152.90 and Rs 75.00 as of 19-Mar-2026.
Star Source Multi Trade Ltd has a market capitalisation of ₹ 13 Cr as on 18-Mar-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Star Source Multi Trade Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹4.13
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.